Tags : Serum Institute of India

Weekly Snapshot

PharmaShots Weekly Snapshots (Feb 15- 19, 2021)

RedHill Signs a Manufacturing Agreement with Cosmo for Movantik and RHB-204  Published: Feb 19, 2021 | Tags: RedHill, Signs, Manufacturing, Agreement, Cosmo, Movantik, RHB-204 Astellas and Seagen Reports Submission of Two BLA to the US FDA for Padcev (enfortumab vedotin) in Locally Advanced or Metastatic Urothelial Cancer Published: Feb 19, 2021 | Tags: Astellas, Seagen, Reports, Submission, […]Read More

Biotech

Novavax and Serum Institute of India Collaborate to Develop and

Shots: Novavax to receive royalties on the sales of vaccines and will provide its Matrix-M vaccine adjuvant to SII. Additionally, the company gets right to commercialize SII-manufactured vaccine in high-income countries, primarily in the travelers and military vaccine markets SII gets access to utilize Novavax’s Matrix-M vaccine adjuvant with its malaria vaccine candidate (R21 malaria […]Read More

Biotech COVID-19

Codagenix Collaborates with Serum Institute of India to Co-Develop a

Shots: Codagenix will utilize its deoptimization technology for viral deoptimization, designed several nCoV vaccine candidate genomes, will grow and conduct in-vivo tests of vaccine viruses prior to testing in clinical studies The Serum Institute of India will scale up the manufacturing of vaccines to ensure its availability to meet the public needs. The companies are […]Read More